Profile

is a branch of immunology that studies interactions between the immune system and cancer cells. It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, is of particular interest in the field as knowledge gained drives the development of targeted therapy and tumor marker-based diagnostic tests.

International Journal of Cancer Immunology & Immunotherapy

  • is an international peer reviewed journal devoted towards cancer immuology & immunotherapy. All the articles published under IJCII, include high quality papers, which cover all the major field cancer immuology. IJCII keeps updating day-to-day research & development to the scientific niche around the world. The journal publishes original articles, commentary, editorials, letters to the editor, review articles and case report describing original research in the fields of cancer immunology.

Editorial Managing System

  • Graphy Publications supports scientist who sweats for the real innovation & discovery in the field of science, technology and medicine. Our online Editorial Managing System (EMS) provides quality and quick editorial process towards rapid publication, so that the author can support the scientific community with wide scientific information. Advanced automated Editorial Managing System simplifies the publication process and helps the author to get track of their articles. The IJCII is Open Access publication to maintain a common relation among the common public and researcher by providing wide scientific information.

IJCII Open Access

  • As IJCII is an international Open Access journal, all the articles published under this journal will be accessible to all internet users throughout the world without any barrier of access under the terms of the Creative Commons Attribution License. International Journal of Cancer Immunology & Immunotherapy (IJCII) covers publication of novel concepts, new methods, new regimens, new technologies, alternative approaches and promises to provide most authentic and complete source of information on current development in the field of cancer immunology.

To submit manuscript click here or send as an e-mail attachment to the Editorial Office at editor.ijcii@graphyonline.com.